EP 1389113 A1 20040218 - USE OF N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVEA AGAINST MAST CELL-BASED DISEASES LIKE ALLERGIC DISORDERS
Title (en)
USE OF N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVEA AGAINST MAST CELL-BASED DISEASES LIKE ALLERGIC DISORDERS
Title (de)
VERWENDUNG VON N-PHENYL-2-PYRIMIDINAMIN- DERIVATIVEN GEGEN AUF MASTZELLEN BASIERENDE ERKRANKUNGEN, WIE Z.B. ALLERGISCHE ERKRANKUNGEN
Title (fr)
UTILISATION DES DERIVES DE N-PHENYL-2-PYRIMIDINEAMINE CONTRE DES MALADIES D'ORIGIN DES MASTOCYTES, COMME DES ALLERGIES
Publication
Application
Priority
- GB 0108606 A 20010405
- US 0210742 W 20020405
Abstract (en)
[origin: WO02080925A1] Use of the N-phenyl-2-pyrimidine-amine derivatives of formula I, in which the symbols and substituents have the meaning as given herein in free form or in pharmaceutically acceptable salt form in the manufacture of a pharmaceutical composition for the treatment of allergic rhinitis, allergic dermatitis, drug allergy or food allergy, angioedema, urticaria, sudden infant death syndrome, bronchopulmonary aspergillosis, multiple sclerosis or mastocytosis.
IPC 1-7
IPC 8 full level
A61K 31/506 (2006.01); A61P 37/08 (2006.01)
CPC (source: EP KR)
A61K 31/505 (2013.01 - KR); A61K 31/506 (2013.01 - EP); A61P 35/00 (2017.12 - EP); A61P 37/08 (2017.12 - EP)
Citation (search report)
See references of WO 02080925A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02080925 A1 20021017; AU 2002307140 B2 20060216; BR 0208663 A 20040309; CA 2443092 A1 20021017; CN 1529602 A 20040915; CZ 20032705 A3 20040616; EP 1389113 A1 20040218; GB 0108606 D0 20010523; HU P0303751 A2 20050428; HU P0303751 A3 20050628; IL 158061 A0 20040328; KR 20040007485 A 20040124; KR 20090034998 A 20090408; MX PA03009058 A 20041122; NO 20034414 D0 20031002; NO 20034414 L 20031204; NO 325454 B1 20080505; NZ 528934 A 20061027; PL 363080 A1 20041115; RU 2003130635 A 20050210; RU 2304436 C2 20070820; SK 12312003 A3 20040203; ZA 200307563 B 20040421
DOCDB simple family (application)
US 0210742 W 20020405; AU 2002307140 A 20020405; BR 0208663 A 20020405; CA 2443092 A 20020405; CN 02808970 A 20020405; CZ 20032705 A 20020405; EP 02763956 A 20020405; GB 0108606 A 20010405; HU P0303751 A 20020405; IL 15806102 A 20020405; KR 20037012939 A 20031002; KR 20097003644 A 20090223; MX PA03009058 A 20020405; NO 20034414 A 20031002; NZ 52893402 A 20020405; PL 36308002 A 20020405; RU 2003130635 A 20020405; SK 12312003 A 20020405; ZA 200307563 A 20030929